NCT01484574View on ClinicalTrials.gov

A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2016

Conditions
Critical Limb IschemiaBuerger's Disease
Interventions
BIOLOGICAL

Allogeneic Mesenchymal Stem Cells

Single intramuscular administration of low dose of stem cells

BIOLOGICAL

Allogeneic Mesenchymal Stem Cells

Single intramuscular administration of intermediate dose of stem cells

Trial Locations (10)

110029

Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi

122001

Division of Peripheral Vascular and Endovascular Sciences, Medanta - The Medicity, Gurgaon

560066

Department of Vascular and Endovascular Surgery, M. S. Ramaiah Medical College and Hospitals, Bangalore

560069

Peripheral Vascular Surgery, Sri Jayadeva Institute of Cardiovascular Sciences & Research, Bangalore

575001

Department of Surgery, KMC, Mangalore, Mangalore

600003

Department of Vascular Surgery, Madras Medical College, Chennai

600116

Department of Vascular Surgery, Sri Ramchandra Medical College, Chennai

700029

Department of Vascular Surgery, AMRI Hospital, Kolkata

700071

Nightingale Hospital, Kolkata

91-44-24732266

Department of Vascular Surgery, Stanley Medical College, Chennai

All Listed Sponsors
lead

Stempeutics Research Pvt Ltd

INDUSTRY

NCT01484574 - A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease | Biotech Hunter | Biotech Hunter